The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Knowledge Center

Patent

Application of high dose compounds via inhalation for treatment of pulmonary diseases

Jan 01, 2013 WO 2013104892

Article

New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit

Oct 01, 2012 Drug Development and Delivery, October 2012

Article

Seeking Solutions in Solid-State Chemistry

Oct 01, 2012 Pharmaceutical Technology, October 2012

Article

Supplier Qualification. A comparison of comprehensive third-party excipient GMP audit programs

Oct 01, 2012 Pharmaceutical Technology, October 2012

Article

Sphere of Influence

May 01, 2012 PMPS, May 2012

Article

Sphere of Influence

May 01, 2012 PMPS, May 2012

Article

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Jan 01, 2012 Separation and Purification Technology (2012), 86, 79-87

Article

Carcinogenic pollutants in drug manufacturing

Jan 01, 2012 Magyar Kemikusok Lapja (2012), 67(2), 34-37

Article

Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids

Jan 01, 2012 Journal of Pharmaceutical and Biomedical Analysis (2012), 70, 251-258

Article

Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions

Jan 01, 2012 Separation and Purification Technology (2012), 86, 190-198

Patent

Preparation of electrophilic sulfur reagents for monohalomethylation of steroids

Jan 01, 2012 WO 2012056201

Patent

Manufacture of a triiodinated contrast agent via a new compound of (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid

Jan 01, 2012 WO 2012175903

Browser not supported

Knowledge Center

Scientific Article Type

Authors

Publish Date

Application of high dose compounds via inhalation for treatment of pulmonary diseases

New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit

Seeking Solutions in Solid-State Chemistry

Supplier Qualification. A comparison of comprehensive third-party excipient GMP audit programs

Sphere of Influence

Sphere of Influence

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Carcinogenic pollutants in drug manufacturing

Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids

Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions

Preparation of electrophilic sulfur reagents for monohalomethylation of steroids

Manufacture of a triiodinated contrast agent via a new compound of (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid